1.5.2024
HELSINKI, Finland - May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation therapy treatment planning workflows. Contour+ accelerates the contouring process, provides guidance…
Press Releases
19.2.2024
Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI's successful award of the tender from the Republic…
8.1.2024
January is Cervical Cancer Awareness Month, and these three core principles are emphasized during the 2024 campaign. Nowadays, cervical cancer is responsible for more than 300,000 deaths each year globally. Fortunately, we have the tools to prevent it, diagnose it early, and treat it efficiently in most cases. This is…
Articles
16.1.2023
The generation of synthetic images has greatly advanced in recent years due to the progress of artificial intelligence. Some of the applications have recently been widely popularized in media, especially art and fashion generation and videos/photos creation of realistic-looking human facesÂą. The image-to-image translation is a special case of synthetic…
7.1.2022
According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…
News
29.12.2021
2021 is an innovative and foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…
24.11.2021
Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a dose of radiation to a tumor. SBRT aims to employ the highest possible dose of radiation to kill cancer while minimizing damage to surrounding tissues…
29.9.2021
Helsinki - 29th of September 2021 - MVision AI, the leading service provider of guideline compliant radiotherapy software, announces a new distribution partnership with AQUILAB, the chief provider of revolutionary oncology software solutions throughout France. (more…)
News, Press Releases
14.9.2021
About the client Docrates is a Finnish private hospital, providing high-quality and prompt cancer care with the latest technologies. Operating for almost 15 years, Docrates’ network of oncological experts has extensive knowledge of the diagnosis and treatment of various cancers. Docrates helps over 1500 cancer patients annually. 30% of Docrates’…
2.8.2021
GDPR has been a hot topic over the last few years. In the past 12 months, there have been over 4,400 google searches related to GDPR, and the UK government will remain GDPR compliant after leaving the EU. The amount of people searching for answers related to GDPR further shows…
22.7.2021
Radiotherapy and radiology are both vital to the cancer treatment process. It is easy for patients to confuse the role that radiotherapy and radiology play in the cancer treatment process. Although radiotherapy and radiology may sound similar, each serves a different and very important purpose in oncology. (more…)
16.7.2021
Did you know that more than 60% of cancer patients will receive radiation therapy, a local treatment that is based on the use of ionizing radiation to cause damage to tumor cells and prevent the growth and proliferation, at some point in the treatment? The quality and atmosphere of radiotherapy…
Subscribe to get information, latest news and other interesting offers about MVision AI
